| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/29/2006 | WO2006042996A3 Method for determining the state of a wooden support |
| 06/29/2006 | WO2006040551A3 Compartmentalised screening by microfluidic control |
| 06/29/2006 | WO2006037421A3 Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
| 06/29/2006 | WO2006027468A3 Hla-dp4 restricted t cd4+ du vih epitopes and the use thereof |
| 06/29/2006 | WO2006026808A8 Method of diagnosing and/or predicting the development of an allergic disorder |
| 06/29/2006 | WO2006025990A3 Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use |
| 06/29/2006 | WO2006025053B1 Methods and kits for the detection of biotoxis and antibiotic residues |
| 06/29/2006 | WO2006021893A3 Pharmaceutical compositions comprising inhibitors of iron transport, and method of identifying iron transport inhibitors, fn staphylococcus aureus |
| 06/29/2006 | WO2006020915A3 Detecting fungi in human samples |
| 06/29/2006 | WO2006020319A3 Methods and compositions for producing target cell reactive lymphocytes in a subject |
| 06/29/2006 | WO2006017644A3 Improved closed-loop light intensity control and related fluorescence application method |
| 06/29/2006 | WO2006017293A3 Models and methods for nociception, pain transduction, and screening for analgesic compounds |
| 06/29/2006 | WO2006008661A3 Diagnostic methods of multiple organ amyloidosis |
| 06/29/2006 | WO2006005740A3 P75ntr screening assay for indentifying modulators of apoptosis |
| 06/29/2006 | WO2006003657B1 Indicator strip and a device for automatic testing of liquids |
| 06/29/2006 | WO2005124352A3 Method for determining aggrecanase activities |
| 06/29/2006 | WO2005118790A3 Combinatorial marking of cells and cell structures with reconstituted fluorescent proteins |
| 06/29/2006 | WO2005107412A3 Systems and methods for reconstruction gene networks in segregating populations |
| 06/29/2006 | WO2005087793A3 Immunostimulatory compositions and uses thereof |
| 06/29/2006 | WO2005080417A3 Recombinant viruses with heterologous envelope proteins |
| 06/29/2006 | WO2005043142A3 Pavement material microwave density measurement methods and apparatuses |
| 06/29/2006 | WO2005033877A3 Knowledge-based storage of diagnostic models |
| 06/29/2006 | WO2005019242A8 Recombinant expression of the hag1 antimicrobial peptide: use as fusion partner for the expression of alpha helical antimicrobial peptides |
| 06/29/2006 | WO2005001092A3 Compositions and methods for diagnosing and treating cancers |
| 06/29/2006 | WO2004066942A3 Purification and uses of dendritic cells and monocytes |
| 06/29/2006 | WO2004044125A3 Vesicle-associated proteins |
| 06/29/2006 | WO2001092277A8 Metallocenes as signal-transducer for detection of chemical or biological events |
| 06/29/2006 | US20060143724 Transgenic mice containing anaphylatoxin C3a gene disruptions |
| 06/29/2006 | US20060143718 Transgenic animals for monitoring water quality |
| 06/29/2006 | US20060142953 Device and method for determining and/or monitoring a process variable of a medium |
| 06/29/2006 | US20060142669 Urine sampling container |
| 06/29/2006 | US20060142548 Methods of identifying and designing cell surface receptor inhibitors |
| 06/29/2006 | US20060142547 Anktm1, a cold-activated trp-like channel expressed in nociceptive neurons |
| 06/29/2006 | US20060142229 Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 06/29/2006 | US20060142196 Soluble GDNFR (Glial-cell Derived Neurotrophic Factor) that retains both ligand binding, and receptor signaling function (via Ret receptor tyrosine kinase) used to impart, restore, or enhance GDNFR alpha -ligand (preferably GDNF) responsiveness to cells; kidney diseases |
| 06/29/2006 | US20060142187 Methods for modulating cell-to-cell adhesion using an agonist of C1INH-type protein activity |
| 06/29/2006 | US20060141639 chromatography test strips comprising a mobile or mobilizable detectable tracer area, a sample application area and capture areas comprising binding partners, used for detection and/or quantitative analysis of samples |
| 06/29/2006 | US20060141638 Equine relaxin as a measure of treatment efficacy |
| 06/29/2006 | US20060141637 injecting and mixing surfactants with a fluid stream consisting of hydrocarbon gas, hydrocarbon liquids and water, flowing in a pipe to form a uniform foam, then withdrawing a portion of the foam and sampling for compositional analysis |
| 06/29/2006 | US20060141633 Method and system for characterization and mapping of tissue lesions |
| 06/29/2006 | US20060141632 New methods and kits for sequencing polypeptides |
| 06/29/2006 | US20060141631 Quantitation of biological molecules |
| 06/29/2006 | US20060141630 Computerized method and apparatus for analyzing amino acids |
| 06/29/2006 | US20060141629 Method and system for determining platelet-mediated clot formation |
| 06/29/2006 | US20060141628 High resolution flow cytometer |
| 06/29/2006 | US20060141619 Apparatus and method for machining microchamber for cell culture |
| 06/29/2006 | US20060141617 Multilayered microcultures |
| 06/29/2006 | US20060141610 Microarray devices having controllable reaction volume |
| 06/29/2006 | US20060141580 Encoding protein with immunomodulatory activity, antiviral activity, and antitumor activity; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals |
| 06/29/2006 | US20060141579 Cytokine zcytor17 ligand polynucleotides |
| 06/29/2006 | US20060141560 Estrogen receptor genes and utilization thereof |
| 06/29/2006 | US20060141554 Site-specific labeling of affinity tags in fusion proteins |
| 06/29/2006 | US20060141551 Using propionyl L-carnitine or a pharmaceutically acceptable salt thereof, for preparing a medicament for the treatment of erectile dysfunction |
| 06/29/2006 | US20060141550 Novel metabolic targets and markers |
| 06/29/2006 | US20060141548 Immunoassays for everolimus |
| 06/29/2006 | US20060141547 Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis |
| 06/29/2006 | US20060141546 Bacterial test method by glycated label binding |
| 06/29/2006 | US20060141545 Cancer treatment kits using antibodies to aminophospholipids |
| 06/29/2006 | US20060141544 Compositions for binding to assay substrata and methods of using |
| 06/29/2006 | US20060141543 Method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring cellular retinoic acid binding protein II in said sample; can be used in the early detection or diagnosis of breast cancer |
| 06/29/2006 | US20060141542 Alpha-amylase assay and uses thereof |
| 06/29/2006 | US20060141541 Using antiphospholipid autoantibody expression profile as evaluative tool in screening for alzheimer's disease |
| 06/29/2006 | US20060141540 Direct selection of cells by secretion product |
| 06/29/2006 | US20060141539 Toxin detection and organ localization; quantitative analysis; high throughput assay |
| 06/29/2006 | US20060141538 Automatic large-scale screening of cells secreting monoclonal antibodies |
| 06/29/2006 | US20060141537 Device and method for separating molecules |
| 06/29/2006 | US20060141536 Using a phosphor that has an emission maximum of 480-900 nm and a cooled charge coupled device for detecting radiation emitted by the phosphor as part of the detection system; phosphor may be an inorganic host doped with a rare earth activator or a rare earth organic chelate |
| 06/29/2006 | US20060141535 Hyaluronan receptor for endocytosis |
| 06/29/2006 | US20060141533 Rapid identification of conditions, compounds, or compositions that inhibit, prevent, induce, modify, or reverse transitions of physical state |
| 06/29/2006 | US20060141532 Administering a nonapeptide of amino acid sequence Leu-Leu-Val-Leu-Leu-Tyr-Ser-Lys-Leu or decapeptide of sequence Leu-Leu-Gln-Leu-Gly-Tyr-Ser-Gly-Arg-Leu comprising an HLA/human leukocyte antigen binding motif increase cytotoxic T lymphocytes (CTL) response to antigens |
| 06/29/2006 | US20060141531 Self-assembled relay probe; peptide tag bound to the target material; a fluorescent conjugate, a fluorochrome and a tag binding group; conjugate selectively associates with the first tag; a second peptide tag bound to the target material with a second fluorochrome having a longer wavelength |
| 06/29/2006 | US20060141530 Using arsenic-mediated labeling to permit orthogonal molecule-specific, site-specific labeling of target molecules, such as proteins, with multiple labels; complex of peptide with tag of a cyanine dye having pendant 2,5-dithia-arsacyclopentane groups |
| 06/29/2006 | US20060141529 Compositions, kits and assays containing reagents directed to cortactin and an ARG/ABL protein kinase |
| 06/29/2006 | US20060141528 Compositions and methods for quantification of serum glycoproteins |
| 06/29/2006 | US20060141527 Method for creating a reference region and a sample region on a biosensor and the resulting biosensor |
| 06/29/2006 | US20060141526 Genetic marker for coronary artery disease |
| 06/29/2006 | US20060141525 Use of lectin library for distinguishing glycoproteins or cells, diagnosing serum or cells, or fractionating glycoproteins or cells |
| 06/29/2006 | US20060141524 Novel kinases and uses thereof |
| 06/29/2006 | US20060141522 Screening methods for identifying agonists and antagonists of hereulin -like factor (HLF) activity; diagnostic methods for detecting disorders of the regulation of cell growth and therapeutic methods for treating disorders of the regulation |
| 06/29/2006 | US20060141507 Manufacture and use of non-standard size microarray slides |
| 06/29/2006 | US20060141506 Methods for monitoring the expression of alternatively spliced genes |
| 06/29/2006 | US20060141503 Detection of sequence variation of nucleic acid by shifted termination analysis |
| 06/29/2006 | US20060141500 Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents useful in the treatment of inflammatory disease |
| 06/29/2006 | US20060141496 Method of screening substance interacting with ABC protein |
| 06/29/2006 | US20060141490 MyD88 as a therapeutic target for cancer |
| 06/29/2006 | US20060141486 Porous substrates and arrays comprising the same |
| 06/29/2006 | US20060141484 Reactive ion etched substrates and methods of making and using |
| 06/29/2006 | US20060141475 Polynucleotide sequence detection assays and analysis |
| 06/29/2006 | US20060141474 Biomolecule detecting element and method for analyzing nucleic acid using the same |
| 06/29/2006 | US20060141473 Erk7 and erk8, novel diagnostic markers for cancer |
| 06/29/2006 | US20060141471 Assay for detection of renal cell carcinoma |
| 06/29/2006 | US20060141470 Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof |
| 06/29/2006 | US20060141469 Multi-layered electrochemical microfluidic sensor comprising reagent on porous layer |
| 06/29/2006 | US20060141460 Assays for fprl-1 ligands |
| 06/29/2006 | US20060141459 Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases |
| 06/29/2006 | US20060141456 Methods and compositions for milieu-dependent binding of a targeted agent to a target |
| 06/29/2006 | US20060141455 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 06/29/2006 | US20060141454 detection of mesenchymal tumoral cells by using the Slug (zinc fingers domains) gene; biomarker |
| 06/29/2006 | US20060141453 Prokineticin polypeptides, related compositions and methods |
| 06/29/2006 | US20060141451 Guinea pig proteinase-activated receptor 4 and its activating peptide |